Skip to content
Austin Top 50
Author:
Classover Holdings Inc.
Lilly’s triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications
June 8, 2026
KIDZ AI Announces Reverse Stock Split
June 4, 2026
KIDZ AI Enters Strategic Collaboration With XuanYuan Technology to Expand AI Education Into Physical, Agent-Powered Learning Environments
June 3, 2026
KIDZ AI Announces Strategic Treasury Pivot to Hyperliquid Ecosystem and Yield-Bearing Stablecoin Strategies
June 2, 2026
KIDZ AI Enters Exclusive Co-Development Partnership with ICreate Education Technology to Launch AI-Native Robotics Learning Platform for North America
June 1, 2026
KIDZ AI INC. Amends $500 Million Secured Convertible Financing Facility to Accelerate AI Infrastructure, Data Center, and Robotics Strategy
May 29, 2026
Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association’s 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care
May 28, 2026
Foundayo and Zepbound now covered for millions of Americans
May 28, 2026
Classover Announces Neocloud Infrastructure Partnership With Cyfuture.ai
May 28, 2026
Classover appoints Cloud & AI Infrastructure Architect, Abdalrahman Nasser, as Corporate Advisor to support Cloud & AI Infrastructure Strategy
May 27, 2026
←
Previous Page
1
2
3
4
5
Next Page
→